Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 391.21M |
| Enterprise Value | 693.72M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.85 |
| Price/Book (mrq) | 0.56 |
| Enterprise Value/Revenue | 3.46 |
| Enterprise Value/EBITDA | -2.50 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.83 |
| 52-Week Change 3 | -86.74% |
| S&P500 52-Week Change 3 | 21.23% |
| 52 Week High 3 | 14.5500 |
| 52 Week Low 3 | 1.2500 |
| 50-Day Moving Average 3 | 4.3226 |
| 200-Day Moving Average 3 | 8.1032 |
Share Statistics
| Avg Vol (3 month) 3 | 9.63M |
| Avg Vol (10 day) 3 | 16.59M |
| Shares Outstanding 5 | 267.95M |
| Implied Shares Outstanding 6 | 267.95M |
| Float 8 | 266.46M |
| % Held by Insiders 1 | 2.80% |
| % Held by Institutions 1 | 101.38% |
| Shares Short (Mar 28, 2024) 4 | 49.05M |
| Short Ratio (Mar 28, 2024) 4 | 5.76 |
| Short % of Float (Mar 28, 2024) 4 | 20.29% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 18.31% |
| Shares Short (prior month Feb 29, 2024) 4 | 43.54M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -152.97% |
| Operating Margin (ttm) | -142.14% |
Management Effectiveness
| Return on Assets (ttm) | -10.92% |
| Return on Equity (ttm) | -48.53% |
Income Statement
| Revenue (ttm) | 200.52M |
| Revenue Per Share (ttm) | 0.79 |
| Quarterly Revenue Growth (yoy) | 113.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -287.2M |
| Net Income Avi to Common (ttm) | -306.74M |
| Diluted EPS (ttm) | -1.2100 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 634.42M |
| Total Cash Per Share (mrq) | 2.37 |
| Total Debt (mrq) | 933.93M |
| Total Debt/Equity (mrq) | 133.17% |
| Current Ratio (mrq) | 7.81 |
| Book Value Per Share (mrq) | 2.62 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -259.17M |
| Levered Free Cash Flow (ttm) | -306.52M |
© 2024 Yahoo. All rights reserved.